This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Okafor, L.A. Articles by Oronsaye, A.U. Search for Related Content PubMed PubMed Citation Articles by Okafor, L.A. Articles by Oronsaye, A.U. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB FOLIC ACID IRON Medline Plus Health Information High Risk Pregnancy Social Bookmarking                         What's this?

Bone Marrow Status of Anaemic Pregnant Women on Supplemental Iron and Folic Acid in a Nigerian Community

From the Department of Haematology, University of Benin Teaching Hospital, Benin City, Nigeria

F.M.E. Diejomaoh

From the Departments of Obstetrics and Gynaecology, University of Benin Teaching Hospital, Benin City, Nigeria

A.U. Oronsaye

From the Departments of Obstetrics and Gynaecology, University of Benin Teaching Hospital, Benin City, Nigeria

The bone marrow status of 31 consecutive pregnant women who had been on supplemental oral iron and folic acid since early pregnancy at the University of Benin Teaching Hospital was assessed later in pregnancy to test the efficacy of oral iron and folic acid in preventing iron deficiency and/or megaloblastic anae mia in our community. Only those pregnant patients with haemoglobin geno type AA or AS took part in the study. Nobody was excluded except those with CC or SC. 96.77% (30 out of 31 patients) had iron deficiency with no stainable iron in the bone marrow. 35.4% (11 out of 31 patients) had megloblastic changes in the bone marrow. 32.2% (10 out of 31 patients) had a combined iron deficiency and megaloblastic anaemia while only one out of 31 patients (3.23%) had megaloblastic anaemia without concurrent iron deficiency. 60.4% (20 out of 31 patients) had iron deficiency alone without concomitant megaloblastic changes in marrow. The bone marrow in all the patients were normal in other respects except with regards to iron-deficiency and/or megaloblastic status.

The significance of this high incidence of iron-deficiency and/or megaloblas tic anaemia in patients already on routine pre-natal drugs is discussed.

Angiology, Vol. 36, No. 8, 500-503 (1985)
DOI: 10.1177/000331978503600804


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?